Seeq Diagnostics
SeeQ Diagnostics' technology is based on know-how developed in Professor Mads Albertsen's group at Aalborg University in Denmark during rapid viral variant tracking for SARS-CoV-2. This was converted into a concept,"SepSeeQ", generally applicable for any pathogen and applied in a prospective observational clinical study (n=40) at Aalborg University Hospital emergency ward. Here SepSeeQ had 100% sensitivity compared to gold-standard blood culture with MALDI-TOF pathogen identification (n=11), and further identified a relevant pathogen in an additional 11 patients (https://journals.asm.org/doi/10.1128/spectrum.03295-24)
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Seeq Diagnostics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
Showing 1 of 4 verified contacts
Top roles at Seeq Diagnostics
2 distinct titles indexed · top 2 shown.
- 3co-founder
- 1bd and bioinformatics, co-founder
Sign up to unlock all 4 contacts at Seeq Diagnostics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Seeq Diagnostics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.